Status:
COMPLETED
Vitamin D Supplementation in Childhood Atopic Dermatitis
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the therapeutic role of vitamin D supplementation in a subset of patients with atopic dermatitis (AD): children with disease onset or worsening in the...
Eligibility Criteria
Inclusion
- Age 2-17 years
- AD rated 10-72 by EASI scale
- Wintertime onset or exacerbation of AD
Exclusion
- Active skin infection
- History of summertime onset or exacerbation of AD
- History of underlying illness causing immunosuppression within the past 2 years (eg. hematologic malignancies)
- Medications causing iatrogenic immunosuppression (eg. cyclosporine; azathioprine, oral steroids) taken within the past month
- Parathyroid disease
- Acute or chronic renal disease
- Hypercalcemia or hypocalcemia
- Thyroid disease
- History of osteomalacia or Paget's disease of bone
- History of malabsorption (eg cystic fibrosis)
- Planned trip to sunny climate during the one-month study
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00879424
Start Date
February 1 2009
End Date
May 1 2009
Last Update
December 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Dermatology Center
Ulaanbaatar, Mongolia